Stockreport

NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates

NexImmune, Inc.  (NEXI) 
PDF Advancing two lead product candidates in Phase 1/2 clinical trials Additional clinical and preclinical data anticipated by year end 2021 and first half 2022Announced col [Read more]